Jan 2, 2018   SOURCE: PR NewsWire

United States Left Atrial Appendage Closure Devices Market 2018

DUBLIN, Jan. 2, 2018 /PRNewswire/ --

The "US Market Report for Left Atrial Appendage Closure Devices 2018 - MedCore" report has been added to Research and Markets' offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Atrial fibrillation (AF) is an abnormal heart rhythm. Patients with AF experience episodes of rapid and irregular beating. As a result of irregular beating, the atrium in AF patients does not completely contract, impeding the flow of blood from the atria into the ventricles. Blood that is not expelled from the left atria collects in the sac-shaped LAA. Once in the LAA, movement of the blood slows. As blood slows, it tends to clot. Strokes can be caused when blood clots are pumped out of the heart. As a result of increased blood clot formation, AF patients are five to seven times more likely to suffer a stroke than those without AF.

Some patients with AF take a blood thinner, such as warfarin (Coumadin), to reduce the risk of stroke. However, many AF patients dislike taking warfarin due to the increased risk of bleeding, the need to limit vitamin K intake and the increased need for blood draws to measure their international normalized ratio (INR). LAA closure devices were developed as an alternative method of reducing the risk of stroke in AF patients. LAA closure devices are used to seal off the LAA, preventing clot formation in the LAA and eliminating the need for the patient to take blood-thinning medication.

The left atrial appendage (LAA) is a small pouch in the wall of the left atrium. It is unknown what function the LAA performs.
In patients with normal heart rhythm, the heart contracts with each heartbeat. As the heart contracts, blood is pushed from the left atrial appendage into the left atrium and from the left atrium into the left ventricle.

Key Topics Covered:

Executive Summary

1. Research Methodology

2. Disease Overview

    --  Coronary Artery Disease
    --  Myocardial Infarction
    --  Angina Pectoris
    --  Heart Valve Disease
    --  Congestive Heart Failure

3. Product Portfolio

    --  Devices
    --  Fda Recalls
    --  Clinical Trials

4. Left Atrial Appendage Closure Device Market

    --  Introduction
    --  Market Overview
    --  Market Analysis And Forecast
    --  Drivers And Limiters
    --  Competitive Market Share Analysis

Companies Mentioned 

    --  Edwards Lifesciences
    --  St. Jude Medical
    --  Medtronic
    --  Maquet
    --  Abiomed
    --  HeartWare Inc.
    --  Sorin Group
    --  Terumo
    --  Abbott Laboratories
    --  Teleflex Medical
    --  Cardiac Assist
    --  AtriCure
    --  W.L. Gore
    --  SynCardia
    --  Boston Scientific
    --  Cryolife
    --  Berlin Heart
    --  Cardica
    --  Chase Medical
    --  Genesee Biomedical
    --  Karl Storz
    --  LifeNet Health
    --  Microline Surgical
    --  Novadaq
    --  On-X
    --  Saphena Medical
    --  SentreHeart
    --  Vitalitec

For more information about this report visit https://www.researchandmarkets.com/research/j3ptbw/united_states?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/united-states-left-atrial-appendage-closure-devices-market-2018-300576449.html

SOURCE Research and Markets